1/29
two flashacrds to add at the end abut how to answer certain questions, see notes
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
antigen
foreign molecule/protein/glycoprotein/glycolipid
that stimulates an immune response leading to production of antibody
how are cells identified by the immune system
each type of cell has specific molecules on its surface
often proteins have a tertiary structure
what type of cells and molecules can the immune system identify (4)
pathogens
cells from other organisms of the same species
abnormal body cells e.g. tumour cells
toxins released by some bacteria
describe phagocytosis of pathogens (non-specific immune response)
phagocyte attracted by chemicals / recognises antigens on pathogen
phagocyte engulfs pathogen by surrounding it with its cell membrane
pathogen contained in vesicle / phagosome in cytoplasm of phagocyte
lysosome fuses with phagosome and releases lysozymes (hydrolytic enzymes)
lysozymes hydrolyse/digest pathogen
where are antigens displayed
phagocytosis leads to presentation of antigens where antigens are displayed on the phagocyte cell surface membrane
stimulating the specific immune response
describe response of T lymphocytes to a foreign antigen ( the cellular response)
T lymphocytes recognise antigen presenting cells
specific helper T cells with complementary receptors bind to antigen on antigen presenting cell - activated and divide by mitosis to form clone which stimulate
cytotoxic T cells - kill infected cells / tumour cells
specific B cells (humorous response)
phagocytes - engulf pathogens by phagocytosis
describe the response of B lymphocytes to a foreign antigen (the humoral response)
colonial selection
specific B lymphocyte with complementary receptor binds to antigen
this is then stimulated by helper T cells
so divides by mitosis to form clones
some differentiate into B plasma cells - secrete large amount of antibody
some differentiate into B memory cells - remain in blood for secondary immune response
antibodies
quaternary structure proteins
secreted by B lymphocytes
bind specifically to antigens forming antigen - antibody complexes
structure of antibody
explain how antibodies lead to the destruction of pathogens
antibodies bind to antigen on pathogens forming an antigen-antibody complex
specific tertiary structure so binding site/ variable region binds to complementary antigen
each antibody binds to 2 pathogens at a time causing agglutination of pathogens
antibodies attract phagocytes
phagocytes bind to antibodies and phagocytose many pathogens at once
primary immune response
first exposure to antigen
antibodies produced slowly and at a lower concentration
takes time for specific B plasma cells to be stimulated to produce specific antibodies
memory cells produced
secondary immune response
second exposure to antigen
antibodies produced faster and at a higher concentration
B memory cells rapidly undergo mitosis to produces many plasma cells which produce specific antibodies
vaccine
injection of antigens from attenuated (dead or weakened) pathogens
stimulating formation of memory cells
explain how vaccines provide protection to individuals against disease
specific B lymphocyte with complementary receptor binds to antigen
specific T helper cell binds to antigen presenting cell and stimulates B cell
B lymphocyte divides by mitosis to form clones
some differentiate into B plasma cells which release antibodies
some differentiate into B memory cells
on secondary exposure to antigen, B memory cells rapidly divide by mitosis to produce B plasma cells
these release antibodies faster and at a higher concentration
explain how vaccines provide protections for populations against disease
herd immunity - large proportion of population vaccinated reducing spread of pathogen
large proportion of population immune so do not become ill from infection
fewer infected people to pass pathogen on / unvaccinated people less likely to come in contact with someone with disease
active immunity
initial exposure to antigen
memory cells involved
antibody produced and secreted by B plasma cells
slow - takes longer to develop
long term immunity as antibody can be produced in response to a specific antigen again
passive immunity
no exposure to antigen antibodies produced
no memory cells produces
antibody introduced from another organism
faster acting
short term
effect of antigen variability on disease and disease presentation
antigens pathogens change shape/tertiary structure due to gene mutations
no longer immune
B memory cell receptors cannot bind to / recognise changed antigen on secondary exposure
specific antibodies not complementary / cannot bind to changed antigen
e.g. yearly flu vaccines
structure of HIV particle
replication of HIV in helper T cells
HIV attachment proteins attach to receptors on helper T cell
lipid envelope fuses with cell surface membrane releasing capsid into cell
capsid uncoats, releasing RNA and reverse transcriptase
reverse transcriptase converts RNA to DNA
viral DNA inserted into helper T cell DNA
viral protein/capsid/enzymes are produced
DNA transcribed into new HIV mRNA
HIV mRNA translated into new HIV proteins
virus particles assembled and released from cells
explain how HIV causes the symptoms of AIDS
HIV infects and kills helper T cells as it multiplies rapidly
so helpers T cells can’t stimulate cytotoxic T cells, B cells and phagocytes
so B plasma cells can’t release as many antibodies for agglutination & destruction of pathogens
immune system deteriorates - more susceptible to infections
pathogens reproduce, release toxins and damage cells
explain why antibiotics are ineffective against viruses
viruses do not have structures that antibiotics inhibit:
viruses don’t not have metabolic processes / ribosomes
viruses do not have bacterial enzymes / murein cell wall
monoclonal antibody
antibodies produced from genetically identical / cloned B lymphocytes / plasma cells
so have same tertiary structure
explain how monoclonal antibodies are used in medical diagnosis
monoclonal antibody has a specific tertiary structure/binding site/variable region
complementary to specific receptor / protein / antigen associated with diagnosis
dye / stain / fluorescent marker attached to antibody
antibody binds to receptor / protein / antigen forming antigen-antibody complex
direct ELISA test to detect antigens
attach sample with potential antigens to well
add complementary monoclonal antibodies with enzymes attached - bind to antigens if present
wash well - remove unbound antibodies
add substrate - enzymes created products that cause a colour change
sandwich ELISA
attach specific monoclonal antibodies to well
add sample with potential antigens, then wash well
add complementary monoclonal antibodies with enzymes attached - bind to antigens if present
wash well - remove unbound antibodies (prevents false positive)
add substrate - enzymes create products that cause a colour change
use of antibodies in the ELISA test to detect antibodies
indirect ELISA
attach specific antigens to well
add sample with potential antibodies, wash well
add complementary monoclonal antibodies with enzymes attached - bind to antibodies if present
wash well - remove unbound antibodies
add substrate - enzymes create products that cause a colour change
what does ELISA stand for
enzyme-linked immunosorbent assay
what is the purpose of a control well in the ELISA test
compare to test to show only enzyme causes a colour change
compare to test to show all unbound antibodies have been washed away
discuss ethical issues with the use of vaccines and monoclonal antibodies
pre clinical testing on animals - potential harm, but animals not killed and helps produce new drugs to reduce human suffering
clinical trials on humans - potential side effects
vaccines - may continue high risk activities and pass on pathogen
use of drug - potentially dangerous side effects